Skip to main content

Breast Cancer Research and Treatment

Ausgabe 1/2017

Inhalt (35 Artikel)

Review

Breast cancer neoplastic seeding in the setting of image-guided needle biopsies of the breast

Lumarie Santiago, Beatriz E. Adrada, Monica L. Huang, Wei Wei, Rosalind P. Candelaria

Preclinical study

A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells

Yoko Chihara, Masafumi Shimoda, Ami Hori, Ako Ohara, Yasuto Naoi, Jun-ichiro Ikeda, Naofumi Kagara, Tomonori Tanei, Atsushi Shimomura, Kenzo Shimazu, Seung Jin Kim, Shinzaburo Noguchi

Preclinical study

21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer

Gulisa Turashvili, Joanne F. Chou, Edi Brogi, Monica Morrow, Maura Dickler, Larry Norton, Clifford Hudis, Hannah Y. Wen

Preclinical study

Analysis of molecular subtypes for the increased HER2 equivocal cases caused by application of the updated 2013 ASCO/CAP HER2 testing guidelines in breast cancer

Lei Guo, Pei Yuan, Jing Zhang, Yun Ling, Wenbin Li, Bohui Zhao, Jianming Ying, Lixue Xuan

Preclinical study

Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome

P. Miller, K. M. Kidwell, D. Thomas, M. Sabel, J. M. Rae, D. F. Hayes, B. I. Hudson, D. El-Ashry, M. E. Lippman

Preclinical study

Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients

Hang Liu, Jingxuan Wang, Minghui Zhang, Qijia Xuan, Zhipeng Wang, Xin Lian, Qingyuan Zhang

Preclinical study

A functional BRCA1 coding sequence genetic variant contributes to prognosis of triple-negative breast cancer, especially after radiotherapy

Meng Shi, Fei Ma, Jibing Liu, Huaixin Xing, Hui Zhu, Jinming Yu, Ming Yang

Preclinical study

Functional importance of PP2A regulatory subunit loss in breast cancer

Lauren F. Watt, Nikita Panicker, Abdul Mannan, Ben Copeland, Richard G. S. Kahl, Matthew D. Dun, Barbara Young, Severine Roselli, Nicole M. Verrills

Open Access Preclinical study

Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution

Melody L. Stallings-Mann, Ethan P. Heinzen, Robert A. Vierkant, Stacey J. Winham, Tanya L. Hoskin, Lori A. Denison, Aziza Nassar, Lynn C. Hartmann, Daniel W. Visscher, Marlene H. Frost, Mark E. Sherman, Amy C. Degnim, Derek C. Radisky

Clinical trial

Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer

John V. Hegde, Xiaoyan Wang, Deanna J. Attai, Maggie L. DiNome, Amy Kusske, Anne C. Hoyt, Sara A. Hurvitz, Joanne B. Weidhaas, Michael L. Steinberg, Susan A. McCloskey

Clinical trial

Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography

Kathleen Van Dyk, Aimee M. Hunter, Linda Ercoli, Laura Petersen, Andrew F. Leuchter, Patricia A. Ganz

Clinical trial

Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers

Cesar A. Santa-Maria, Megan Kruse, Paola Raska, Mia Weiss, April Swoboda, Martin B. Mutonga, Jame Abraham, Sarika Jain, Rita Nanda, Alberto J. Montero

Epidemiology

Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women

María Elena Martínez, Scarlett L. Gomez, Li Tao, Rosemary Cress, Danielle Rodriguez, Jonathan Unkart, Richard Schwab, Jesse N. Nodora, Linda Cook, Ian Komenaka, Christopher Li

Erratum

Erratum to: Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women

María Elena Martínez, Scarlett L. Gomez, Li Tao, Rosemary Cress, Danielle Rodriguez, Jonathan Unkart, Richard Schwab, Jesse N. Nodora, Linda Cook, Ian Komenaka, Christopher Li

Epidemiology

Medical costs of treating breast cancer among younger Medicaid beneficiaries by stage at diagnosis

Justin G. Trogdon, Donatus U. Ekwueme, Diana Poehler, Cheryll C. Thomas, Katherine Reeder-Hayes, Benjamin T. Allaire

Open Access Epidemiology

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population

Johanna I. Kiiski, Anna Tervasmäki, Liisa M. Pelttari, Sofia Khan, Tuomo Mantere, Katri Pylkäs, Arto Mannermaa, Maria Tengström, Anders Kvist, Åke Borg, Veli-Matti Kosma, Anne Kallioniemi, Johanna Schleutker, Ralf Bützow, Carl Blomqvist, Kristiina Aittomäki, Robert Winqvist, Heli Nevanlinna

Epidemiology

Breast cancer risk prediction: an update to the Rosner–Colditz breast cancer incidence model

Megan S. Rice, Shelley S. Tworoger, Susan E. Hankinson, Rulla M. Tamimi, A. Heather Eliassen, Walter C. Willett, Graham Colditz, Bernard Rosner

Epidemiology

Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer

Anthony F. Yu, Roy B. Mukku, Shivani Verma, Jennifer E. Liu, Kevin C. Oeffinger, Richard M. Steingart, Clifford A. Hudis, Chau T. Dang

Epidemiology

Radiation-related heart disease after breast cancer radiation therapy in Korean women

Jee Suk Chang, Byung Kyun Ko, Jeoung Won Bae, Jong-Han Yu, Min Ho Park, Yongsik Jung, Ye Won Jeon, Kyung Hwan Kim, Jaeyong Shin, Chang-Ok Suh, Yong Bae Kim

Open Access Epidemiology

Pharmaceutically treated anxiety but not depression prior to cancer diagnosis predicts the onset of cardiovascular disease among breast cancer survivors

Dounya Schoormans, Lonneke van de Poll-Franse, Pauline Vissers, Myrthe P. P. van Herk-Sukel, Susanne S. Pedersen, Nina Rottmann, Trine Horsbøl, Susanne Dalton, Johan Denollet

Epidemiology

Diagnosis and treatment delays among elderly breast cancer patients with pre-existing mental illness

Kristy Iglay, Melissa L. Santorelli, Kim M. Hirshfield, Jill M. Williams, George G. Rhoads, Yong Lin, Kitaw Demissie

Epidemiology

CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study

D. L. Hertz, K. M. Kidwell, S. G. Hilsenbeck, S. Oesterreich, C. K. Osborne, S. Philips, C. Chenault, R. J. Hartmaier, T. C. Skaar, M. J. Sikora, J. M. Rae

Epidemiology

Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers

Diana R. Withrow, Lindsay M. Morton, Rochelle E. Curtis, Sara J. Schonfeld, Amy Berrington de González

Epidemiology

Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer

Jacky D. Luiten, Adri C. Voogd, Ernest J. T. Luiten, Lucien E. M. Duijm

Brief Report

Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient

Scolastica W. Njoroge, Kelly R. Burgess, Melody A. Cobleigh, Hussein H. Alnajar, Paolo Gattuso, Lydia Usha

Erratum

Erratum to: Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells

Daniela Bonofiglio, Sabrina Gabriele, Saveria Aquila, Hongyan Qi, Maria Belmonte, Stefania Catalano, Sebastiano Andò

Erratum

Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial

Javier Cortés, Hope S. Rugo, Ahmad Awada, Chris Twelves, Edith A. Perez, Seock–Ah Im, Patricia Gómez-Pardo, Lee S. Schwartzberg, Veronique Diéras, Denise A. Yardley, David A. Potter, Audrey Mailliez, Alvaro Moreno-Aspitia, Jin-Seok Ahn, Carol Zhao, Ute Hoch, Mary Tagliaferri, Alison L. Hannah, Joyce O’Shaughnessy

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.